chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One week following vaccination, he had a slight fever, degrees unknown, a white coating on the inside of his mouth and tongue, and a macular rash on neck, trunk of body, legs.  He has not been treated; still has same symptoms.
This spontaneous report as received from a healthcare worker refers to an unspecified patients of unknown age and gender. There was no information about concomitant medications, concurrent condition and medical history of patients reported. On an unknown date, improperly stored doss of GARDASIL 9 (dose, site, route of administration, lot# and expiry date were not reported) was administered to unspecified patients. No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient called immunizing pharmacist on 6/28/12 to report red, swollen reaction at injection site (left arm/deltoid). Area hard and approximately 2-3 inches in diameter.
Patient called the clinic reporting that he continues to have pain at the injection site in his right arm.  He originally called to see what vaccine he was given in that arm.  He describes the pain as "right where the shot was given".  He denies any redness, swelling or firmness at the injection site and he denies any pain in the right shoulder joint.  He states that he has to take both Tylenol and advil pm to be able to sleep at night due to the discomfort.  He relates having difficulty laying on his right side due to the discomfort.  He states he is able to move his arm in full range of motion but if his Tylenol/advil has worn off, it is more painful to move the arm.
Patient was given her shot, she got up and sat down in the nearest observation chair, then immediately said she was dizzy and thought she was going to pass out. I went to her and she repeated that she was about to pass out. When her head started to roll back I was able to hold her by her shoulders. Her eyes rolled back and her head dropped back and she started convulsing. She lost consciousness for about 10 seconds. When she came to she didn't know what was happening. She was very sweaty by this time. I asked if she had a history of seizures or had ever fainted before and she answered no. EMS was called. I checked her BP and it was 84/41. The patient tried to stand to assist with finding her husband in the store but I told her she had to sit until EMS arrive. We offered her water and orange juice and she asked for both. When the husband got there we asked him if she has a history of fainting or seizures and he said this has happened multiple times, mostly as a result of seeing blood. He said she hasn't had seizures but she has had tremors when this has happened. I checked her BP again and it was 116/88. She was feeling a lot better. EMS arrived and she was stable by that point. They recommended that she go to the hospital, but patient opted not to go.
Patient is 8 and received the Pfizer vaccine for those aged 12 and up.
Nauseated; Experienced chills; 24 hours later sore left arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nauseated), CHILLS (Experienced chills), PAIN IN EXTREMITY (24 hours later sore left arm) and HEADACHE (Headache) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A and 038K20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu Vaccine in 2021. Past adverse reactions to the above products included No adverse event with Flu Vaccine. Concurrent medical conditions included Seafood allergy and Seafood allergy. Concomitant products included VITAMIN D NOS for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 03-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 04-Apr-2022, the patient experienced NAUSEA (Nauseated), CHILLS (Experienced chills), PAIN IN EXTREMITY (24 hours later sore left arm) and HEADACHE (Headache). On 05-Apr-2022, CHILLS (Experienced chills), PAIN IN EXTREMITY (24 hours later sore left arm) and HEADACHE (Headache) had resolved. At the time of the report, NAUSEA (Nauseated) had resolved.            No Treatment information was provided.  Other medications: Preservision Vitamins, Low dose blood pressure medication- For use as a Prevention   This case was linked to MOD-2022-533478 (Patient Link).   Reporter did not allow further contact
My arm was just sore after the first covid shot.  No further issues with the first shot.  After the second shot my arm was sore similar to the first shot.  The next morning however I awoke with ringing/roaring in both my ears.  Sometimes the ringing in the left ear will get very loud and high pitch for a couple of minutes then go back down to the same level of ringing/roaring in my right ear.  I have never had ringing/roaring in my ears before this time in my whole life.  I waited a couple of months to see if it would go away, but it has not and it continues even to this day.  It is ringing 24 hours a day.  I occasional high pitch jump in the left ear also has continued.
Received vaccine while 32.1 week pregnant; Arm soreness at injection site; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while 32.1 week pregnant) and INJECTION SITE PAIN (Arm soreness at injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 28-May-2020 and the estimated date of delivery was 04-Mar-2021. On 08-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while 32.1 week pregnant) and INJECTION SITE PAIN (Arm soreness at injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 08-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while 32.1 week pregnant) had resolved. At the time of the report, INJECTION SITE PAIN (Arm soreness at injection site) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jun-2020, Pregnancy test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No treatment information provided.; Reporter's Comments: This is a case of product exposure during pregnancy with  associated AEs for this 30-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy .Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient was supposed to get her second dose of Pfizer Covid 19 but was given a dose of Covid19(Janssen) by mistake
30 year old female with fever, delerium and severe headache one hour post IPV #2, Hep B #2. Also left sided numbness and pain. Fever and delerium subsided but left sided numbness and pain, HA continued.
The patient is not experiencing (nor has she ever experienced) any side effects; interchange of vaccine products; inappropriate schedule of vaccine administered; This spontaneous report was received from a nurse practitioner referring to a 20-month-old female patient. The patient's pertinent medical history, concomitant drugs and allergy to drugs were not reported.     . On 22-APR-2019, 26-AUG-2019 and 28-FEB-2020, she was vaccinated with hib conj vaccine (tet toxoid)(ACTHIB) (dose, strength, lot number and expiration date were not reported) intramuscularly for prophylaxis three times. On 24-JUN-2019, the patient was vaccinated with Hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (MRC-5), tetanus toxoid (PENTACEL) (dose, strength, lot number and expiration date were not reported) intramuscularly for prophylaxis. On 20-OCT-2020, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (lot number was S021458, expiration date was 27-FEB-2022, dose and strength were not reported) intramuscularly for prophylaxis (Interchange of vaccine products, Inappropriate schedule of product administration). The patient is not experiencing (nor has she ever experienced) any side effects.
lips started feeling tingle and numb and couldn't catch breath, heart racing and tightness in chest
heated, diaphoretic, collapsed in checkout desk hallway, RN present and caught patient, guided down to floor and laid patient down flat with feet up. Lying flat - color improved within 2 mins, BP 119/71 HR 72 RR 22; denied nausea/ dizziness, BP 123/79 HR 81; sitting - denied nausea/ dizziness BP 131/76 HR 89; Standing - denied nausea/ dizziness - BP 127/82 HR 83. Patient was given water and apple juice and sent to sub waiting area, denied any symptoms at this time' patient was observed for an additional 10 minutes.
I've been sick for a long time; Kind of numb; like I have Bell's palsy, paralyze some part of my face, the right side/ I have paralyze some part of my face/started on my left (side) then it moved over to my right (side); I can't form my words; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (like I have Bell's palsy, paralyze some part of my face, the right side/ I have paralyze some part of my face/started on my left (side) then it moved over to my right (side)) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included OXYCODONE for Back pain, METOPROLOL, HYDROCHLOROTHIAZIDE and GABAPENTIN for an unknown indication.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Sep-2021, the patient experienced BELL'S PALSY (like I have Bell's palsy, paralyze some part of my face, the right side/ I have paralyze some part of my face/started on my left (side) then it moved over to my right (side)) (seriousness criterion medically significant) and SLOW SPEECH (I can't form my words). On an unknown date, the patient experienced ILLNESS (I've been sick for a long time) and HYPOAESTHESIA (Kind of numb). At the time of the report, BELL'S PALSY (like I have Bell's palsy, paralyze some part of my face, the right side/ I have paralyze some part of my face/started on my left (side) then it moved over to my right (side)) had not resolved and ILLNESS (I've been sick for a long time), SLOW SPEECH (I can't form my words) and HYPOAESTHESIA (Kind of numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient taking medication for pressure as a concomitant.  Patient reported that she experienced paralyze some part of her face, the right side. It started on her left side then it moved over to her right side. The paralysis started on 14Sep2021 and it is still ongoing.  Company comment: This case concerns a 54 year old female who experienced serious unexpected event of Bell's palsy 4 days after the receiving the first dose of the Moderna vaccine. No medical history provided. Dechallenge is unknown and rechallenge is not applicable.  The benefit-risk relationship is not affected by this report for the Moderna vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Additional information received on 15-Sep-2021 which updated events and concomitant products.; Sender's Comments: This case concerns a 54 year old female who experienced serious unexpected event of Bell's palsy 4 days after the receiving the first dose of the Moderna vaccine. No medical history provided. Dechallenge is unknown and rechallenge is not applicable.  The benefit-risk relationship is not affected by this report for the Moderna vaccine.
Body rash hives all over within 20 minutes swelling red and itchy sere eczema flare up
Left arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm soreness) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced VACCINATION SITE PAIN (Left arm soreness). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Vaccination site pain, at an unspecified dose and frequency. On 30-Mar-2021, VACCINATION SITE PAIN (Left arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications provided included Contraceptive pills.
Discharge Physician: Primary Care Physician: Date of Admission: 8/22/2022; Discharge Date: 8/24/2022; Room Number: 2020/2020-1; PRESENTING PROBLEM: Weakness [R53.1]; Generalized weakness [R53.1]; COVID-19 [U07.1]HOSPITAL COURSE:A 79 y.o. female who presents today with weakness and fatigue. The patient is somewhat forgetful and cannot give many details about duration of symptoms. She reports that she started feeling ill two days ago however was seen in the ER at Hospital on 8/18 with report of symptoms starting a day or so before this visit. She has been having significant fatigue, weakness, a cough, sore throat and poor appetite. Many of her family members have had COVID. She tested positive on a home test and was given a prescription for paxlovid in the ER on 8/18. Her husband was admitted to the hospital last night and son had concerns about the patient's ability to care for herself at home so she was brought to the ER for evaluation.  In the ER the patient had labs which were mostly unremarkable. Her sodium was a bit lower than her recent baseline at 128. She was COVID positive. Her CXR was negative. She was not hypoxic. She was admitted to the hospitalist team for PT/OT evaluation and possible placement.  She was continued on IV fluid with improvement of sodium.  PT/OT evaluated advised home health PT/OT and return to assisted living.  Patient unable to return to assisted living until completion of quarantine for which patient's family was agreeable to watching her patient and spouse until end quarantine. Electrolytes were monitored and repleted PRN throughout the admission. TFTs were updated and she had notable improvement of TSH. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
C/o numbness on (L) side of face. Felt like she was "drooling". Treated with Prednisone x 3 days.
She tested positive to COVID on 29DEC2020; She tested positive to COVID on 29DEC2020; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, lot no. and expiry date were unknown), via an unspecified route of administration on 21Dec2020 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was tested positive to COVID on 29Dec2020. She received the 1st dose of the vaccine on 21Dec2020. She is due for the 2nd dose on 11Jan2020. They asked if she should still receive the 2nd dose. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Instead, the positive COVID likely represents the pre-existing infection prior to vaccine use.  Further information like confirmative COVID 19 Nucleic acid/ PCR test together with any associated symptoms are needed for full medical assessment.
I woke up the day after getting the shingrix and pneumovax shots, feeling totally like crap, and felt worse as the day wore on. I was achy and my stomach was upset, my head ached and my neck was stiff and sore, and I couldn't focus on anything. My fever got up to 101.7. I contacted my insurance plan's teledoctor service. The doctor said that it was the shingrix shot and she sees a lot of it, and told me to take both ibuprofen and tylenol. I took aspirin and tylenol. This caused me to miss work on Monday, and interfered with my productivity at work on Tuesday. It cleared up slowly and was gone by Tuesday afternoon. 7/9 (72 hours) I had such brain fog I couldn't remember the word for hard drive. My job is testing computer RAM and hard drives.  As a result of this I doubt I'm going to get the second shot. It isn't worth it! I wasn't this sick when I had CHICKEN POX, nor the last two times I had the flu! My sister's had shingles, and to the shot, she said, NOPE!
Information has been received from a patient's aunt and mother concerning a 6 year old male who on 10/27/1995 was vaccinated with Varicella virus vaccine live. On approximately 03/22/01, the patient developed a mild case of chickenpox with less than 20 lesions. Unspecified medical attention was sought. In follow-up, the patient's physician reported that the patient transferred out of the practice on 03/03/1998. The patient's aunt and his mother also reported on the patient's siblings who also had an experience following vaccination with varicella virus vaccine live. No further information is available.
Excursion in the refrigerator with maximum 49.3 F and minimum 45.8 F temperature/ the refrigerator door was left open for 10 minutes; patient were administered the Moderna Covid 19 vaccine after it suffered a temperature excursion; No adverse reaction; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion in the refrigerator with maximum 49.3 F and minimum 45.8 F temperature/ the refrigerator door was left open for 10 minutes), POOR QUALITY PRODUCT ADMINISTERED (patient were administered the Moderna Covid 19 vaccine after it suffered a temperature excursion) and NO ADVERSE EVENT (No adverse reaction) in a 35-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 013H22A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion in the refrigerator with maximum 49.3 F and minimum 45.8 F temperature/ the refrigerator door was left open for 10 minutes), POOR QUALITY PRODUCT ADMINISTERED (patient were administered the Moderna Covid 19 vaccine after it suffered a temperature excursion) and NO ADVERSE EVENT (No adverse reaction). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion in the refrigerator with maximum 49.3 F and minimum 45.8 F temperature/ the refrigerator door was left open for 10 minutes), POOR QUALITY PRODUCT ADMINISTERED (patient were administered the Moderna Covid 19 vaccine after it suffered a temperature excursion) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion in the refrigerator with maximum 49.3 F and minimum 45.8 F temperature/ the refrigerator door was left open for 10 minutes) and POOR QUALITY PRODUCT ADMINISTERED (patient were administered the Moderna Covid 19 vaccine after it suffered a temperature excursion).    Concomitant medication of the patient was not reported.  Reporter reported that the refrigerator door was left open for ten minutes. Maximum and minimum temperatures reported were 49.3 degree Fahrenheit and 45.8 degree Fahrenheit respectively. There were 2 Unpunctured and1 punctured vial Lot number 060A22A and MFG Exp. Date: 28AUG2022 and 1 Punctured vial Lot number 013B22A and  MFG Exp. Date: 22NOV2022. Vials were moved from freezer to refrigerator on 25Jul2022. It was further reported that the unpunctured vial was still in the refrigerator and the punctured ones were discarded. The vials looked normal.  No treatment details were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-627779 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2022: Live Follow Up received Lot number and Narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-627779:
78y/o F received Flu Vaccine on 9/17/20. (Pt previously received flu vaccines in 2014, 2015, 2017, 2018 with no note of any reactions). Pt with PMHx notable for HTN, presented to ED on 9/27/20. Symptoms started as soon as she woke up, around 9 AM on the day of presentation. She experienced numbness in the right foot first, then left foot shortly after. Numbness continues to persist and progresses upwards to her legs and thighs. She also reports falling onto her buttocks this morning as she was leaving the house to go to the hospital. She states her legs "just gave out". No head injury, syncope, lightheadedness, or dizziness associated with the fall. No slurred speech, vision changes, urinary or bowel incontinence, or weakness or numbness of upper extremities, or lumbar pain. She states she had the flu vaccination on 9/17 and experienced mild headache and myalgias afterwards, which quickly resolved with Tylenol. No other recent respiratory or gastrointestinal illness. No camping/hiking trips or sick contacts. No fevers/chills, nausea/vomiting, cough, rhinorrhea, shortness of breath, chest pain, abdominal pain, diarrhea, urinary symptoms.  Investigations:  CSF showed 0 WBC with 57 protein.  Non-contrast MRI of the spine showed no acute pathology.   Impression:  Acute onset symmetric sensorimotor neuropathy.  Likely GBS based on the clinical presentation.   -No respiratory involvement this admission, breathing on RA comfortably  -Received 5 days IVIG in hospital By 10/16/20 the patient is back to 95% of baseline.  She has been advised to have no further influenza vaccination.
Information has been received from a registered nurse concerning an 18 year old female with arthritis and PEDIAZOLE allergy who on 05-JAN-2007 at 10:30 AM was vaccinated with Pneumovax 23 (0.5 ml), subcutaneously in the left arm.  Concomitant therapy "a few days" prior included REMICADE (IV), in the left hand.  On 05-JAN-2007 the patient presented to the office with local site reaction of cellulitis at the injection site of the left arm.  The patient was treated with comfort measures PRN.  There were no relevant diagnostic tests or laboratory data.  At the time of the report the patient was considered to be not recovered.  Additional information has been requested.